Endometrial stromal sarcoma: A systematic review

Obstetrics and Gynecology

Volumn 122, Issue 3, 2013, Pages 676-683

  Rauh Hain, J Alejandro ^a   Del Carmen, Marcela G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; ANTIESTROGEN; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOCETAXEL; DOXORUBICIN; ESTROGEN; GEMCITABINE; GESTAGEN; GONADORELIN; IFOSFAMIDE; IMATINIB; LETROZOLE; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE; MEGESTROL; MEGESTROL ACETATE; MITOMYCIN; PACLITAXEL; TAMOXIFEN; VINBLASTINE; VINCRISTINE;

ADJUVANT THERAPY; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; DRUG CONTRAINDICATION; ENDOMETRIUM SARCOMA; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; LEUKOPENIA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MESENCHYME; MULTIMODALITY CANCER THERAPY; OVARIAN PRESERVATION; PATHOGENESIS; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT CANCER; SALPINGOOOPHORECTOMY; STANDARD; UTERUS CANCER;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; SARCOMA, ENDOMETRIAL STROMAL;

EID: 84883252626     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3182a189ac     Document Type: Article

References (39)

1. Norris HJ, Taylor HB. Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer 1996;19: 755-66.
2. World Health Organization classification of tumours. Mesenchymal tumors and related lesions. In:Tavassoli FA, Devilee P, editors. Pathology and genetics of tumours of the breast and female organs. Lyon (France): IARC Press; 2003. p. 233-6.
3. Yilmaz A, Rush DS, Soslow RA. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation. Am J Surg Pathol 2002;26: 1142-50 (Pubitemid 34969183)
4. Xue WC, Cheung AN. Endometrial stromal sarcoma of the uterus. Best Pract Res Clin Obstet Gynaecol 2011;25: 719-32.
5. Baker P, Oliva E. Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques. J Clin Pathol 2007;60: 235-43. (Pubitemid 46447736)
6. Fekete PS, Vellios F. The clinical and histologic spectrum of endometrial stromal neoplasms: a report of 41 cases. Int J Gynecol Pathol 1984;3: 198-212. (Pubitemid 15213605)
7. Hart WR, Yoonessi M. Endometrial stromatosis of the uterus. Obstet Gynecol 1977;49: 393-403. (Pubitemid 8085284)
8. Oliva E, Young RH, Clement PB, Bhan AK, Scully RE. Cellular benign mesenchymal tumors of the uterus. A comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and six endometrial stromal nodules, two frequently confused tumors. Am J Surg Pathol 1995; 19: 757-68.
9. Kurihara S, Oda Y, Ohishi Y, Kaneki E, Kobayashi H, Wake N, et al. Coincident expression of betacatenin and cyclin D1 in endometrial stromal tumors and related high grade sarcomas. Mod Pathol 2010;23: 225-34.
10. Ng TL, Gown AM, Barry TS, Cheang MC, Chan AK, Turbin DA, et al. Nuclear beta-catenin in mesenchymal tumors. Mod Pathol 2005;18: 68-74. (Pubitemid 40128097)
11. Dal Cin P, Talcott J, Abrams J, Li FP, Sandberg AA. Ins (10;19) in an endometrial sarcoma. Cancer Genet Cytogenet 1988;36: 1-5.
12. Sreekantaiah C, Li FP, Weidner N, Sandberg AA. An endometrial stromal sarcoma with clonal cytogenetic abnormalities. Cancer Genet Cytogenet 1991;55: 163-6.
13. Pauwels P, Dal Cin P, Van de Moosdijk CN, Vrints L, Sciot R, Van den Berghe H. Cytogenetics revealing the diagnosis in a metastatic endometrial stromal sarcoma. Histopathology 1996;29: 84-7. (Pubitemid 26232530)
14. Hennig Y, Caselitz J, Bartnitzke S, Bullerdiek J. A third case of a low-grade endometrial stromal sarcoma with a t(7;17)(p14 approximately 21;q11.2 approximately 21). Cancer Genet Cytogenet 1997;98: 84-6. (Pubitemid 27400858)
15. Moinfar F, Kremser ML, Man YG, Zatloukal K, Tavassoli FA, Denk H. Allelic imbalances in endometrial stromal neoplasms: frequent genetic alterations in the nontumorous normal-appearing endometrial and myometrial tissues. Gynecol Oncol 2004;95: 662-71. (Pubitemid 39610411)
16. Chiang S, Oliva E. Cytogenic and molecular aberrations in endometrial stromal tumors. Hum Pathol 2011;42: 609-17.
17. Chang KL, Crabtree GS, Lim-Tan SK, Kempson RL, Hendrickson MR. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 1990;14: 415-38. (Pubitemid 20140662)
18. Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Urgesi A, et al. Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol 1996;63: 247-53. (Pubitemid 26398607)
19. Gadducci A, Cosio S, Romanini A, Genazzani AR. The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol 2008;65: 129-42.
20. Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Pierce VK, Lewis JL Jr. Treatment of endometrial stromal tumors. Gynecol Oncol 1990;36: 60-5. (Pubitemid 20038003)
21. Gadducci A. Prognostic factors in uterine sarcoma. Best Pract Res Clin Obstet Gyneacol 2011;25: 783-95.
22. Garg G, Shah JP, Toy EP, Bryant CS, Kumar S, Morris RT. Stage IA vs IB endometrial stromal sarcoma: does the new staging system predict survival? Gynecol Oncol 2010;118: 8-13.
23. Chan JK, Kawar NM, Shin JY, Osann K, Chen LM, Powell CB, et al. Endometrial stromal sarcoma: a population-based analysis. Br J Cancer 2008;99: 1210-5.
24. Nordal RR, Kristensen GB, Kaern J, Stenwig AE, Pettersen EO, Tropé CG, et al. The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma. Gynecol Oncol 1996;62: 254-9. (Pubitemid 26274808)
25. Bodner K, Bodner-Adler B, Obermair A, Windbichler G, Petru E, Mayerhofer S, et al. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol 2001;81: 160-5. (Pubitemid 32424154)
26. Evans HL. Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 1982;50: 2170-82. (Pubitemid 13203626)
27. Leath CA, Huh WK, Hyde J Jr, Cohn DE, Resnick KE, Taylor NP, et al. A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol Oncol 2007;105: 630-4. (Pubitemid 46734182)
28. Riopel J, Plante M, Renaud MC, Roy M, Têtu B. Lymph node metastases in low-grade endometrial stromal sarcoma. Gynecol Oncol 2005;96: 402-6. (Pubitemid 40127141)
29. Garcia-Martinez E, Lucas EP, Garcia-Donas J, Escolar- Perez PP, Pastor F, González-Martin A. Current management of uterine sarcomas. Clin Trans Oncol 2011;13: 307-14.
30. Abeler VM, Royne O, Thorsen S, Danielsen HE, Nesland JM, Kristensen GB. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology 2009; 54: 355-64.
31. Goff BA, Rice LW, Fleishhacker D, Muntz HG, Falkenbury SS, Nikrui N, et al. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecol Oncol 1993;50: 105-9. (Pubitemid 23235520)
32. Park JY, Kim DY, Kim YM, Kim YT, Nam JH. The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low-grade endometrial stromal sarcoma of the uterus. Ann Surg Oncol 2011;18: 3453-61.
33. Amant F, De Knijf A, Van Calster B, Leunen K, Neven P, Barteloot P, et al. Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma. Br J Cancer 2007;97: 1194-9. (Pubitemid 350035798)
34. Amant F, Coosemans A, Debiec-Rychter M, Timmermamn D, Vergote I. Clinical management of uterine sarcomas. Lancet Oncol 2009;10: 1188-98.
35. Spano JP, Soria JC, Kambouchner M, Piperno-Neuman S, Morin F, Morere JF, et al. Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma. Med Oncol 2003;20: 87-93. (Pubitemid 36344030)
36. Maluf FC, Sabatini P, Schwartz L, Xia J, Aghajanian C. Endomtrial stromal sarcoma: objective response to letrozole. Gynecol Oncol 2001;82: 384-8. (Pubitemid 32730624)
37. Sutton G, Blessing JA, Park R, DiSaia PJ, Rosenshein N. Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group. Obstet Gynecol 1996;87: 747-50. (Pubitemid 26127095)
38. Reed NS, Mangioni C, Malmstrom H, Scarfone G, Poveda A, Pecorelli S, et al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer 2008; 44: 808-18.
39. Cheng X, Yang G, Schmeler KM, Coleman RL, Tu X, Kavanagh JJ. Recurrence patterns and prognosis of endometrial stromal sarcoma and potential of tyrosine kinase-inhibiting therapy. Gynecol Oncol 2011;121: 323-7.